South Korea
· Delayed Price · Currency is KRW Genolution Statistics
Total Valuation
Genolution has a market cap or net worth of KRW 55.94 billion. The enterprise value is 32.31 billion.
| Market Cap | 55.94B |
| Enterprise Value | 32.31B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Genolution has 19.19 million shares outstanding.
| Shares Outstanding | 19.19M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.73% |
| Owned by Insiders (%) | 12.88% |
| Owned by Institutions (%) | 0.08% |
| Float | 14.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.34 |
| PB Ratio | 0.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.85 |
| EV / Sales | 2.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.57 |
Financial Position
The company has a current ratio of 8.27, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.27 |
| Quick Ratio | 7.42 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.00 |
| Interest Coverage | -34.70 |
Financial Efficiency
Return on equity (ROE) is -4.87% and return on invested capital (ROIC) is -3.05%.
| Return on Equity (ROE) | -4.87% |
| Return on Assets (ROA) | -2.95% |
| Return on Capital (ROIC) | -3.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.57% |
| 50-Day Moving Average | 3,378.50 |
| 200-Day Moving Average | 3,755.50 |
| Relative Strength Index (RSI) | 36.76 |
| Average Volume (20 Days) | 116,315 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genolution had revenue of KRW 11.33 billion and -4.72 billion in losses. Loss per share was -517.84.
| Revenue | 11.33B |
| Gross Profit | 6.14B |
| Operating Income | -5.62B |
| Pretax Income | -6.13B |
| Net Income | -4.72B |
| EBITDA | -4.11B |
| EBIT | -5.62B |
| Loss Per Share | -517.84 |
Balance Sheet
The company has 43.27 billion in cash and 19.64 billion in debt, giving a net cash position of 23.63 billion or 1,231.54 per share.
| Cash & Cash Equivalents | 43.27B |
| Total Debt | 19.64B |
| Net Cash | 23.63B |
| Net Cash Per Share | 1,231.54 |
| Equity (Book Value) | 94.90B |
| Book Value Per Share | 5,196.06 |
| Working Capital | 43.68B |
Cash Flow
In the last 12 months, operating cash flow was -407.36 million and capital expenditures -4.51 billion, giving a free cash flow of -4.91 billion.
| Operating Cash Flow | -407.36M |
| Capital Expenditures | -4.51B |
| Free Cash Flow | -4.91B |
| FCF Per Share | -256.12 |
Margins
Gross margin is 54.14%, with operating and profit margins of -49.62% and -41.62%.
| Gross Margin | 54.14% |
| Operating Margin | -49.62% |
| Pretax Margin | -54.06% |
| Profit Margin | -41.62% |
| EBITDA Margin | -36.26% |
| EBIT Margin | -49.62% |
| FCF Margin | -43.36% |
Dividends & Yields
Genolution does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 45.04% |
| Shareholder Yield | 45.04% |
| Earnings Yield | -17.76% |
| FCF Yield | -8.79% |
Stock Splits
The last stock split was on April 19, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Apr 19, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Genolution has an Altman Z-Score of 3.91.
| Altman Z-Score | 3.91 |
| Piotroski F-Score | n/a |